← Back to Drugs A–Z

Tapentadol

Nicknames: Palexia, Tapenta
Last reviewed: October 2026

Pharmacology

Tapentadol is a full agonist at the mu (µ) opioid receptor (see Morphine for more details on opioid receptors) in the central and peripheral nervous systems.

Similar to tramadol, tapentadol also inhibits the recycling of neurotransmitter noradrenaline (NRI) which is thought to help alleviate neuropathic pain. However, tapentadol does not affect serotonin and is 2–3x more potent than tramadol at the µ-opioid receptor. Additionally, tapentadol doesn’t have any active metabolites making it more predictable.

Like tramadol, tapentadol can lower the threshold for seizures. Tramadol has also been shown to cause low blood pressure in some people.

Interactions

The combination of tapentadol with other depressants, such as alcohol and benzodiazepines, is associated with an increase in respiratory depression and overdose. Mixing tapentadol with antidepressants increases the risk of serotonin syndrome.

Keep This Information Independent

Release is a registered charity. We rely on your support to provide expert, non-judgmental legal and harm reduction guidance to thousands of people every year.

Donate to Release